The use of digit ratios as markers for perinatal androgen action by McIntyre, Matthew H
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
Reproductive Biology and 
Endocrinology
Open Access Review
The use of digit ratios as markers for perinatal androgen action
Matthew H McIntyre*
Address: Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston MA 02115, USA
Email: Matthew H McIntyre* - mmcintyr@hsph.harvard.edu
* Corresponding author    
Abstract
Since the ratio of the second-to-fourth finger length was first proposed as a marker for prenatal
androgen action in 1998, over 100 studies have been published that have either further tested the
association between the digit ratio and prenatal androgens, or employed digit ratios as a marker to
investigate the association between prenatal androgens and a variety of outcomes, including
behavior, fertility, and disease risks. Despite the clear demand for an adult marker of prenatal
androgen action and increased use of digit ratios as such a marker, its validity remains controversial.
This review (1) evaluates current evidence for the relationship between digit ratios and prenatal
androgens (using experimentation with animal models, amniotic testosterone, and congenital
adrenal hyperplasia case-control studies), (2) describes opportunities for future validation tests,
and (3) compares the potential advantages and disadvantages of digit ratio measures with more
established methods for studying the effects of prenatal androgens.
Background
Many researchers are pursuing research programmes
aimed at elucidating the effects of early testosterone expo-
sure on later development outcomes, especially behavior.
These include both experimental work with animal mod-
els and a large body of work in human psychology that
have focused on the role of early testosterone action on
behavioral sex differentiation [1]. In addition to the long-
standing work on behavioral outcomes, interest has arisen
more recently in the effects of early testosterone exposure
on health-related outcomes in adulthood, including poly-
cystic ovary syndrome [2,3] and reproductive cancers
[4,5].
The concept of "early testosterone action" is broadly
meaningful in mammals because a period of high testo-
sterone production in males during the prenatal (and pos-
sibly postnatal) periods drives the differentiation of
primary reproductive tissues, and is then followed by a
long period of relative testicular quiescence before the
onset of puberty. Nevertheless, the particular pattern and
timing of early testosterone production varies among spe-
cies, and, more importantly, the pattern and timing of
potential target tissue development varies substantially
both between species and among tissue types. Rodents,
for example, might be expected to show greater potential
effects of postnatal, relative to prenatal, testosterone expo-
sure because of their altricial pattern of development,
whereas primate males (including humans) might be
expected to show greater postnatal effects because they
produce more testosterone in infancy [6]. This review will
focus on the pattern and effects of testosterone production
in human males, with comparisons to animal models
where relevant.
Human male perinatal testosterone production
The mid-gestational peak in human male testosterone
production occurs between the 10th and 18th weeks of ges-
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tation. Testosterone levels then decline, probably for a
combination of reasons including an increase in hypoth-
alamo-pituitary sensitivity to negative feedback, rising
concentrations of placental steroids, and rising prolactin
production [7]. Late pregnancy is presumed to be charac-
terized by much lower testicular activity, as reflected by
the low testosterone concentration, and sex similarity,
found in umbilical cord blood [7-10], though fetal steroid
profiles in the weeks immediately preceding birth have
not been well characterized. Parturition events cause an
LH surge followed after several hours by a surge in testo-
sterone [11]. The proximal causes of the LH surge are not
well understood, but may involve the abrupt removal of
the feedback effects of placental steroids. Serum total tes-
tosterone concentrations in boys fall to childhood levels
by one or two weeks after birth, then rise to a second post-
natal peak beginning at about 8 weeks, and fall again to
childhood levels by 4–6 months [7]. Human perinatal tes-
tosterone production, then, consists of three distinct
peaks, a mid-gestational peak and two postnatal peaks.
Total serum testosterone levels at each of the peaks rise to
just below or within the range of concentrations in adult
men. Sex hormone binding globulin concentration is very
low at birth, but rises rapidly, such that the unbound level
of testosterone is high at the first postnatal peak but low
at the second postnatal peak [7]. This is reflected in the
high concentrations of testosterone in the saliva of one-
week old infants, followed by low concentrations during
the infant peak detected in blood [12,13]. Conversely,
concentrations of dihydrotestosterone are low in the first
weeks after birth but very high during the second postna-
tal peak [14].
Of the three peaks in human perinatal testosterone pro-
duction, the mid-gestational peak is known to have
important biological effects, more or less directly produc-
ing the sex differences observed at birth, but sex differen-
tiation may continue after birth. The testes also grow
especially rapidly during infancy, which might reflect tes-
ticular activity and gonadotropin stimulation [13,15].
Some preliminary evidence also suggests that postnatal
testosterone production in necessary for normal penile
growth in infants [16].
Digit ratios: rationale, methods of 
measurement, sources of error and confounding
As peripheral blood cannot be drawn from fetuses in utero,
and is rarely drawn from infants for research purposes,
those interested in studying effects of perinatal testoster-
one in humans have had to rely on a variety of other
methods. One method which has come into broad use is
finger or digit length ratio measurement, especially the
ratio of the second (index)-to-fourth (ring) fingers
(2D:4D). 2D:4D was proposed as a marker for prenatal
testosterone by John Manning and colleagues in 1998
[17].
Given the complexities of early effects of testosterone on
sex differentiation discussed above, and further complex-
ities associated with the development of the short bones
of the fingers, this review evaluates evidence bearing on
the broader hypothesis that digit ratios, including 2D:4D,
are influenced by perinatal  androgen action, and if so,
whether the effects are large enough and specific enough
to merit their use as biomarkers. The word "prenatal" will
be used where effects can be isolated as such, or if not,
"perinatal" will be used. Moreover, in some cases it will be
possible to refer specifically to "testosterone" or more gen-
erally to "androgens." While most research has focused
specifically on 2D:4D, as will this review, I will also
broaden the discussion to "digit ratios" where appropri-
ate. The review continues with (1) a description of digit
ratio measures, including methods of measurement,
measurement error, and the development of sex differ-
ences, followed by (2) consideration of the potential
involvement of perinatal androgens in the development
of observed sex differences, then (3) evaluation of each
established technique for studying effects of perinatal
androgens, its applications to the validation of digit ratio
measures, and the potential roles of digit ratio measures
to complement the established approach, given their
respective advantages and disadvantages for different
types of research.
The introduction of digit ratios as possible markers for
prenatal androgens [17] follows from the very long-estab-
lished observation that adult men have longer ring fingers
(fourth digits) than adult women relative to the lengths of
other fingers [18-22]. Methods of digit measurement have
followed standard protocols, with most studies measuring
on the skin surface, from photocopies, or from digital
scans, and a few using left side hand-wrist radiographs
originally obtained to assess bone age. Most researchers
have focused digit ratio research specifically on 2D:4D,
with a few exceptions, including authors also measuring
other sex-dimorphic ratios like middle-to-ring finger,
3D:4D [23-25], and researchers using an older method of
assessment, distal extent [22]. In each case, female values
are higher. For 2D:4D measured on the skin surface,
lengths of each finger are determined from the most prox-
imal flexion crease (as two flexion creases often appear at
the base of the fourth digit) to the fingertip. The intra- and
inter-observer repeatability of these measures have been
established by a number of researchers employing 2D:4D
[26].
In adults, the point-biserial correlation between sex and
right-hand, skin-surface 2D:4D is not high, even in
racially homogenous samples (r  = 0.22, ~60% overlapReproductive Biology and Endocrinology 2006, 4:10 http://www.rbej.com/content/4/1/10
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between male and female distributions [17]). Further-
more, the large population and racial differences observed
in both adults [27-29] and children [25,30] could intro-
duce serious confounding. In mixed race samples, race
accounts for more variation in 2D:4D than does sex. Afri-
can-descended populations have lower 2D:4D at all ages,
but substantial differences have also been reported among
national or ethnic groups usually considered racially sim-
ilar [28]. However, the magnitude of sex differences
reported in right-hand, skin-surface 2D:4D have been
similar in different populations, so sex differences appear
to be independent from population differences. The prob-
lem of racial confounding can be avoided by careful study
design, including collection of homogeneous samples
and comparisons within families. Alternative digit ratios,
like 3D:4D, might also reduce racial confounding [25].
The size of the sex difference in right-hand 2D:4D seems
to be smaller in children than adults (r = 0.15, ~90% over-
lap between boys and girls [17]). However, a longitudinal
study using left-hand, radiograph-measured 2D:4D found
larger sex differences at 9 years-old (r = 0.23) than at 17 (r
= 0.18) [24]. Sex differences in 2D:4D were shown to be
unaffected by puberty using a cross-sectional design [17].
Serial measurements have corroborated the finding [24].
However, it is now well established that 2D:4D increases
during childhood in both sexes [24,25,30,31]. The magni-
tude of the change is small, and in children older than five
years old is certainly smaller than the sex difference, but
between ages one and five the increase is greater than the
sex difference. Age should be considered in planning stud-
ies with children.
The development of sex differences in digit ratios during
childhood also constitutes an important source of evi-
dence about the role of testosterone in the sex differentia-
tion of digit ratios. Children over the age of one year
produce very low levels of sex hormones. Therefore, while
sex differences at age five cannot be unambiguously attrib-
uted to either mid-gestational or postnatal testosterone
production, involvement of testosterone in one or both
periods is possible, and involvement of testosterone in
later periods is unlikely.
Possible physiological pathways producing sex 
differences in digit ratios
Sex steroids could directly influence relative bone lengths
either by influencing (1) the development of the phalan-
geal anlagen during the perinatal period, or (2) metaphy-
seal growth. In neither case has specific evidence from the
short bones of the fingers been reported, and inferred
physiology depends on analogy to long bone physiology.
Sex steroid receptors are expressed in various fetal anlagen
[32]. Influences on the anlagen would occur primarily
during the first trimester of gestation, a time of testicular
development and rising androgen production levels in the
male fetus. Effects of sex steroid exposure on the develop-
ment of primordia are difficult to speculate except by
analogy to the better-understood effects of estrogens on
metaphyseal growth. Growth plates organize at one or
both ends of long and short bones at various times during
fetal or infant development (depending on the particular
bone), and account for most elongation. Sex steroids act
on metaphyseal tissue primarily through the estrogen
receptors α and β [33-36]. In adolescent males effects on
long bones are mediated by local aromatization of testo-
sterone [37]. The androgen receptor is also expressed in
growth plates [38], though effects on bone length through
the androgen receptor are unknown.
The simplest understanding of estrogen-receptor-medi-
ated effects on metaphyseal growth is that they promote
fusion of growth plates by the accelerated degeneration of
hypertrophic chondrocytes [35]. In addition, sex steroids,
again apparently through an estrogen pathway [36], pro-
duce the growth spurt associated with the early stages of
puberty. The growth spurt seems to result from the sys-
temic role of sex steroids in the increasing secretion of
growth factors, especially IGF-1, during puberty [39].
Growth-inhibiting effects of estrogens seem to be depend-
ent on their growth-promoting effects, in that hyper-
trophic chondrocytes are stimulated by high levels of
estrogens, become exhausted, and degenerate as a result
[35]. This effect of estrogens on bone growth plays a key
role in the normal pattern of linear growth during
puberty, including growth in stature. Men attain a higher
stature (and generally longer fingers) than women
through hypermorphosis, an extended period of growth
owing to later onset of the pubertal growth spurt, not
through a higher rate of growth. The few men who have
been identified with either estrogen receptor deficiency or
aromatase deficiency present with continued growth in
stature far beyond sexual maturation, and low bone min-
eral density [40].
Sex steroid effects on anlagen or metaphyseal growth
could influence observed differences in relative finger
bone lengths in any of a large number of ways, including
(1) differences among bones in sex steroid sensitivity, or
(2) differences among bones in the sequence of growth
processes, overlaid on temporal fluctuations in testicular
activity. Sex differences in digit ratios could arise if bones
from different fingers are differentially receptive to sex
steroids (because they differ in receptor activity, aro-
matase activity, or present different conditions for interac-
tion between steroid complexes and growth factors). Sex
differences could also arise even if the bones of different
fingers have similar responses to sex steroids but differ in
their temporal patterns of growth. Differences among
bones in the timing of periods of peak growth or onset ofReproductive Biology and Endocrinology 2006, 4:10 http://www.rbej.com/content/4/1/10
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chondrification or ossification, together with changing
sex differences in steroid production, would result in dif-
ferent effects of sex steroids, despite similar patterns of
sensitivity and exposure among bones. Differences in the
timing of growth events have been extensively docu-
mented, both among short bones of the hand [41], and
between the sexes [42,43].
These potential explanations are not exhaustive. The
effects of perinatal steroids might predispose tissues to
divergent patterns of development in later periods.
Whether the role of perinatal androgens in promoting sex
differences in digit ratios are more direct or indirect could
have substantial bearing on the validity of 2D:4D as a spe-
cific marker for perinatal androgens.
Experimental research using animal models
Experimental research into the effects of perinatal andro-
gens in animals has been an important source of insights
about effects in humans. Some generalization among
mammals with respect to testosterone production and
perhaps sensitive periods of some tissues seems war-
ranted. The mid-gestational and first postnatal periods of
male testosterone production are common to all mam-
mals thus far studied, but not chickens [44]. The first post-
natal peak has been described in rats [45,46], mice [47],
horses [44], sheep [48], and in ferrets [49].
However, the value of animal models for studying many
outcomes of interest remains limited, including behavio-
ral sex differences [1], metabolic development [50], and
metastatic prostate cancer [51], to cite just a few examples.
Some problems arise because comparable outcomes are
not observed, and other problems arise because differ-
ences in physiology or in the timing and patterns of devel-
opment complicate etiological comparisions. Therefore,
methods for studying effects of endogenous perinatal
androgens in humans, perhaps including 2D:4D, will
remain important.
Could experiments in non-human models be used to test
the validity of 2D:4D? Interspecies developmental differ-
ences in the digits might also introduce problems with
generalization similar to the outcomes mentioned above.
Even within primates, digital formula can vary substan-
tially. Non-human apes and brachiating monkeys have
shorter thumbs and longer fingers, and also lower 2D:4D.
But if homologous sex differences could be established in
other species, experimentation might help in describing
their common origin.
One study found that a similar sex difference in digit
ratios is found in weanling and adult laboratory mice
[52], which might suggest a taxonomically broad homol-
ogous system where sex differences are concerned. A sim-
ilar sex difference has also been found in the ratios of
Hamadryas baboon metacarpals [53], but an opposite sex
difference has been reported in 2D:4D of living Guinea
baboons [54]. One study has investigated effects on rat
digit ratios of prenatal exposure to alcohol, which is
known to decrease perinatal testosterone levels in rats
[55]. 2D:4D was not significantly altered by the interven-
tion. Research has also proceeded in birds, in which gen-
eralization to humans should be more problematic. One
study found sex differences in digit ratios in zebra finches
[56], but a later study failed to replicate the sex difference
[57]. Another study manipulated yolk testosterone in
ring-necked pheasant eggs and showed an increase in
female 2D:3D on the left foot only [58]. The finding is
especially difficult to interpret because 2D:3D is not one
of the more sex dimorphic ratios in humans and was not
found to be sex dimorphic among the control pheasants.
Furthermore, the effect was opposite the expected direc-
tion and only on the left foot.
Further research into plausible animal models for digit
ratio development, and experiments involving fetal
androgen manipulation, might contribute substantially to
assessing whether sex differences in 2D:4D result from tes-
tosterone action, and if detected, perhaps to describing
the magnitude and dose-responsiveness of the effect, par-
ticular pathways of action, and confounding factors that
could interfere with the use of 2D:4D as a marker. How-
ever, further work must first establish whether useful ani-
mals models exist, including careful characterization of
population mean digit ratios and the development of sex
differences.
Direct measurement of fetal testosterone
As already noted, an important obstacle to the validation
of 2D:4D or any purported adult marker for perinatal
androgen action, is the lack of peripheral blood sampling
from fetuses in utero. However, a number of alternative
methods for direct measurement of fetal androgen levels
have been proposed as useful research tools and one has
been applied to validating 2D:4D.
Amniotic fluid
The mid-gestational surge in male testosterone can be
identified in amniotic fluid [10,59-63], though the sex dif-
ference is smaller than in fetal peripheral blood, as meas-
ured in abortuses, and the correlation between amniotic
testosterone level and peripheral blood level is low [64].
Use of amniotic fluid to study prenatal testosterone also
has several practical disadvantages associated with the use
of amniocentesis in the clinical setting. Samples are
always opportunistic, gestational age cannot be carefully
controlled, and samples cannot be easily collected to test
the validity of amniotic testosterone, the last such test hav-Reproductive Biology and Endocrinology 2006, 4:10 http://www.rbej.com/content/4/1/10
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ing been conducted 20 years ago with negative results
[64].
One study has used amniotic testosterone to test the valid-
ity of digit ratios [65]. Non-significant trends were found
in a group of 29 boys and girls for amniotic fluid testoster-
one to be negatively related to right-hand, but not left-
hand, 2D:4D at two years old, and for estradiol to be pos-
itively related. The ratio of testosterone to estradiol in
amniotic fluid was a significant predictor and explained
just over 20% of the variance in right-hand 2D:4D. How-
ever, the biological significance of estradiol, and of the
testosterone-to-estradiol ratio, in prepubertal sex differen-
tiation is not widely supported by other evidence [40,66].
Bone growth, in which estrogen mediation seems to play
an important role, might be an exception.
Neonatal cord blood
A second approach to direct measurement employs
neonate umbilical cord blood concentrations of testoster-
one in the study of perinatal exposure. As already noted,
levels of testosterone in cord blood are very low and not
correlated with testosterone levels in important periods
[7-10]. That said, sex differences in cord testosterone have
been detected [67]. Umbilical cord blood has not yet been
used to investigate the validity of digit ratios, and would
probably not be promising.
Gravid maternal blood
A third approach to direct measurement uses gravid
maternal testosterone levels to study the effects of andro-
gens in fetuses. This approach is even more controversial
because the association between maternal and fetal sex
steroid levels is not well understood. Gravida hormone
levels provide little, if any, information about fetal pro-
duction [10,68,69], but one study found significantly
higher testosterone in women carrying male fetuses [70].
Conversely, indirect evidence suggests that maternal pro-
duction of androgens may have detectable effects in
female fetuses [71,72]. This method has not been used to
test the validity of digit ratios, and while positive results
would be supportive of digit ratio validity, negative results
certainly could not be construed as evidence against the
role of androgens in digit ratio sex differences.
Setting aside concerns about the validity of the direct
methods of measuring fetal androgens, digit ratios have a
number of practical advantages over all direct methods
and would serve as an important supplemental measure.
While direct measures can be useful for studying out-
comes in infancy and childhood, they are less practical for
studying outcomes in adulthood, such as cancer or cardi-
ovascular disease, which would require very long, expen-
sive prospective studies. Digit ratios can also be measured
and re-measured easily and reliably. While digit ratio
studies require larger numbers of subjects to detect effects
than do amniotic testosterone studies, digit ratios meas-
ures can be collected from many subjects easily, at later
ages, and in non-clinical settings, allowing for larger,
more controlled, and more representative samples.
Co-twin sex
Transfer of testosterone from male fetuses to neighboring
fetuses via amniotic fluid perfusion has been demon-
strated in rodents [73,74], and a similar phenomenon has
been proposed as occurring in human twin pregnancies
[75]. There is no direct evidence to support this claim.
Even if transfer does occur in humans, the effect is small,
as notable masculinization of girls with a male co-twin
has not be observed. Some studies have found evidence of
masculinization of girls with male co-twins [76,77], but
not others [78].
A recent study has compared the left- and right-hand
2D:4D of boys and girls, ranging in age from 4 to 15, who
were in opposite- or same-sex twin pregnancies [79]. They
found that girls with a male co-twin had lower 2D:4D
than girls with a female co-twin, but only on the left hand
(point-biserial  r  = 0.44, ~45% overlap). Testosterone
exposure via amniotic fluid might explain the finding.
Congenital adrenal hyperplasia
Congenital adrenal hyperplasia (CAH) treated soon after
birth has been the gold-standard method for studying
effects of prenatal or perinatal androgens. CAH usually
results from deficiency in 21-hydroxylase, which converts
progestogens into corticoids. Beginning around the 8th
week of gestation, excess adrenal progestogens are
shunted into the androgen pathway, resulting in elevated
concentrations of adrenal androgens: DHEA, DHEA-S,
and androstenedione. Corticosteroid treatments are effec-
tive at reducing androgen production in females and start
immediately upon diagnosis. In the past, genital sex reas-
signment surgery was almost always performed on geni-
tally inter-sex XX individuals affected with CAH, who were
then raised as girls. Extensive research has been conducted
into the possible role of prenatal androgen exposure in
both the gender identity and sex-typed behavior of CAH-
affected people, with conflicting results [80,81].
One study found that 13 females and 7 males with post-
natally-treated CAH had lower 2D:4D (but only on the
right hands of females and left hands of males) than 44
female and 28 male relatives unaffected by CAH [82].
Another study found that 27 females and 9 males with
postnatally-treated CAH had lower 2D:4D (on both
hands of females and only the right hands of males) than
52 female and 52 male age-matched controls unaffected
by CAH [83]. However, a study employing 2D:4D meas-
ured on radiographic films of the left hand failed to find aReproductive Biology and Endocrinology 2006, 4:10 http://www.rbej.com/content/4/1/10
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significant difference between 66 CAH females and 69
age-matched control females and 77 males, though
2D:4D was intermediate between means for unaffected
males and females [31]. All three studies used subjects of
widely varying ages, but two studies matched cases and
controls by age. Given that 2D:4D levels increase with age
in both male and female children, it is possible that addi-
tional error introduced by using subjects of such varying
ages, non-consanguineous controls, or left-hand meas-
ures could account for the different results.
Although [31] used the largest number of cases, their
design was otherwise less ideal than the two studies find-
ing effects, as they included subjects from ages 1 to 20,
encompassing the full period of growth in 2D:4D, appar-
ently matched some cases and controls with age differ-
ences greater than one year, and measured only left-hand
2D:4D. [83] included newborns to 13 year olds, also a
problematic range of ages, but matched age to within two
weeks, and performed analyses separately in subjects
younger and older than two years of age. [82] did not use
age matching, but all subjects were older than five, by
which time 2D:4D is largely established and sex dimor-
phic, and cases were matched with related controls, fur-
ther increasing detection power.
While CAH has been the standard model for studying
effects of prenatal and infant androgen action, it has some
disadvantages not shared by digit ratios. Although
researchers try to include only subjects with similar forms
of CAH and ages at treatment initiation, it can be difficult
to enroll enough cases using strict criteria. Also, as CAH is
a disease, cases and controls differ in ways unrelated to
androgen exposure, which might be relevant for some
outcomes. In cases involving intersex, it is impossible to
distinguish effects of androgens from social and personal
experiences of the intersex body. Even in cases with surgi-
cal modification of the genitalia, some outcomes can be
biased by differences in parental behavior toward the
child and by clinical interventions themselves, including
the experience of the surgery or its effectiveness. As a
result, subjects pools (which are small to begin with) can
be characterized as more or less unrepresentative of non-
clinical populations for many outcomes of interest. A final
drawback is that CAH is most useful for studying the
effects of perinatal androgens in females because diagno-
sis and treatment of males is less consistent, whereas, if
valid, digit ratios would be useful in both males and
females.
Genetic modulation of sex hormone effects
Genetic polymorphisms that specifically modify andro-
gen action can be used to study effects of androgens on
within-sex variation. For example, the amino-terminal
domain of the androgen receptor contains a repeated
series of CAG (glutamine) elements of variable length. In
humans, the repeat is usually 9 to 36 elements long
(mode around 20), varying by population. Within the
normal range, shorter polyglutamine tracts have been
associated, both theoretically and in vitro, with enhanced
androgen receptor transactivation, and thereby increased
masculinization of tissues [84,85].
Higher 2D:4D has been associated with more CAG ele-
ments [86], further supporting a direct association of sex
differences in digit ratios with androgen action. As 2D:4D
was assessed among adults in this study, effects cannot be
definitively isolated to the perinatal period, but given the
developmental pattern of 2D:4D, pubertal period effects
are unlikely. A study relating CAG repeats and 2D:4D
among children would serve as more conclusive evidence
for perinatal effects of androgens.
While genetic polymorphisms with known functional
effects and expression patterns might become important
tools for studying the effects of perinatal androgens, as yet
only the CAG repeat has shown firm evidence for differen-
tial allele function. Moreover, encoded genetic polymor-
phisms, such as the CAG repeat, affect androgen action at
all ages, and would only be applicable to the study of
effects of perinatal androgen action for outcomes meas-
ured in childhood. As digit ratios develop early and are
then fixed, they could be used to study outcomes in child-
hood and adulthood, using either prospective or retro-
spective designs (though combining digit ratio measures
from children and adults is problematic, as discussed
above).
Conclusion
The validity of digit ratios as markers for perinatal andro-
gen action is supported by a number of lines of recently
reported evidence, but further support is needed.
(1) Sex differences in digit ratios develop early in child-
hood and are unaffected by pubertal growth. This seems
to be firmly established.
(2) High amniotic testosterone-to-estradiol ratio predicts
low 2D:4D by two years old. While current evidence is
supportive, further studies using amniotic testosterone or
other direct methods should be conducted.
(3) CAH affected girls have lower 2D:4D than unaffected
controls. This observation is not firmly established and
further studies could help to resolve inconsistencies in the
literature.
(4) The CAG repeat polymorphism of the androgen recep-
tor gene influences 2D:4D as predicted. Further studies
could help to confirm this finding.Reproductive Biology and Endocrinology 2006, 4:10 http://www.rbej.com/content/4/1/10
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Questions remain that might also be answered through
animal or in vitro experimentation, provided that the util-
ity of particular models can be established. For example,
which periods of androgen exposure during the perinatal
period produce observed sex differences in digit ratios?
How do the development of the right and left sides differ
to yield such varying results (even among laboratory
mice)?
Interesting work has already been done using 2D:4D, and
it might one day prove, after further validation, to be a
simple, reliable, and broadly accepted method for study-
ing early human sex differentiation in large, representative
samples. Furthermore, while interest in early testosterone
has been greatest among psychologists, epidemiologists
have also begun to investigate the role of early develop-
ment in disease. Given that more direct measurement of
early testosterone levels is unworkable in most epidemio-
logical study designs, further research would be encour-
aged by the availability of markers such as digit ratios.
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